Intrinsic Value of S&P & Nasdaq Contact Us

MeiraGTx Holdings plc MGTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
46/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$18.00
+59.4%

MeiraGTx Holdings plc (MGTX) generated $-46.36M in operating cash flow for fiscal year 2025. After capital expenditures of $3.83M, free cash flow was $-50.19M.

Free cash flow margin was -61.7% of revenue. Cash conversion ratio was 0.41x, suggesting some earnings are non-cash.

Criteria supported by this page:

  • HEALTH (0/100, Fail) — weak cash flow raises concerns about debt servicing
  • MOAT (56/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
  • INCOME (10/100) — Cash conversion ratio was 0.41x suggests some earnings are non-cash items

Overall SharesGrow Score: 46/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
46/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
→ Valuation
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
56/100
Proven by this page
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income
MeiraGTx Holdings plc Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $-46.36M$-46.36M$-104.5M$-105.37M$-73.1M
Capital Expenditure $-10.32M$-3.83M$-4.96M$-20.17M$-44.96M
Free Cash Flow $-56.68M$-50.19M$-109.45M$-125.54M$-118.06M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message